StonvexLoading…
StonvexStonvexStonvexCore line items from EZPW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $433.48M | $828.90M | $382.02M | $1.27B | $937.47M |
Operating Income | Not available | $128.45M | $60.61M | $149.17M | $112.18M |
Net Income | Not available | $93.41M | $44.30M | $109.61M | $82.91M |
EPS (Diluted) | $0.40 | $1.17 | $0.55 | $1.42 | $1.08 |
Total Assets | Not available | $2.13B | $1.99B | $1.95B | $1.88B |
Total Liabilities | Not available | $984.83M | $916.78M | $925.72M | $893.01M |
Cash & Equivalents | Not available | $354.18M | $465.91M | $469.52M | $472.09M |
Free Cash Flow OCF − CapEx | Not available | $69.70M | $31.69M | $110.42M | $74.68M |
Shares Outstanding | Not available | 83.35M | 83.28M | 83.38M | 83.14M |